Madrigal Pharmaceuticals
MDGL
#2268
Rank
A$10.56 B
Marketcap
$484.59
Share price
-1.58%
Change (1 day)
41.14%
Change (1 year)

EPS for Madrigal Pharmaceuticals (MDGL)

EPS in 2023 (TTM): -$27.99

According to Madrigal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$29.53. In 2022 the company made an earnings per share (EPS) of -$27.28 a decrease over its 2021 EPS that were of -$23.13.

EPS history for Madrigal Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$27.992.62%
2022-$27.2817.93%
2021-$23.1311.61%
2020-$20.72140.18%
2019-$8.63146.61%
2018-$3.50-12.99%
2017-$4.02-91.03%
2016-$44.82-14.83%
2015-$52.636.71%
2014-$49.32-29.92%
2013-$70.3719.81%
2012-$58.746%
2011-$55.417.53%
2010-$51.53-139.74%
2009$129.67-185.4%
2008-$151.83-31.67%
2007-$222.2152.27%
2006-$145.92-27.65%
2005-$201.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.58-94.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.43-98.55%๐Ÿ‡บ๐Ÿ‡ธ USA